In the News
... LII New This Week: June 16, 2005
Get ready for Bloomsday, explore an autopsy, then learn about the Patriot Act, drug safety, the Congress of Racial Equality, Edgar Ray Killen, Emmett Till, lightning, Paul Laurence Dunbar, and more. In More New This Week, read up on carbon sequestration, self-mutilation, and other polysyllabic curiosities. Bon appetit from the LII team: librarian-editors Karen, Wendy, Jennifer, Maria, Pat, Tom, Charlotte, and our 100-and-change contributors. Medicare Modernization Act Did Not Change Chemotherapy As Feared
Cancer patients receiving chemotherapy have not noticed a restriction in their access to treatment following the enactment of the Medicare Prescription Drug, Improvement and Modernization Act of 2003, despite the act's significant reduction in government reimbursement to oncologists, according to a new study. Leprosy Microbes Lead Scientists To Immune Discovery
With the unusual opportunity that human leprosy infections provide for study of human immune responses, scientists have discovered how the body's early warning system prompts a rapid immune response by two separate armies of defensive cells. The finding helps explain why, when threatened by microbes like the leprosy bug, this initial defense sometimes succeeds in limiting the damage, but in other cases yields to a dangerous, spreading infection. New Target For Muscular Dystrophy Drug Therapy Found
Researchers report how the gene for utrophin, which codes for a protein very similar to dystrophin, the defective protein in Duchenne muscular dystrophy, puts the brakes on its own expression in muscle cells, thereby suggesting a new target for treatment. Jan. 25, 1921: The Robot Cometh
Robots have practical use today. But when Karel Capek coined the word, they were just downright creepy. Compiled by Tony Long. Yale Scientists 'See' Basis Of Antibiotic Resistance
Using X-ray crystallography, researchers at Yale have "seen"the structural basis for antibiotic resistance to common pathogenic bacteria, facilitating design of a new class of antibiotic drugs, according to an article in Cell. Steitz and Moore are among the co-founders of Rib-X, a New Haven-based drug discovery company with exclusive license to the high-resolution crystal structure of the ribosome. They project Phase-I trials of their first drug to begin in early 2006. Cognitive Revolution: Integrating Computing, Nanotech, Simulation And
Imagine a world where a machine creates a "virtual you"by modeling how you think and your expertise on a subject. Or one where your car's computer appreciates your driving skills and compensates for your limitations. That's the world Sandia National Laboratories has entered full throttle through its Cognitive Science and Technology Program. 'Strange' Physics Experiment Is Unraveling Structure Of Proton
An international team of nuclear physicists has determined that particles called strange quarks do, indeed, contribute to the ordinary properties of the proton. The experiment, called G-Zero, was performed at Thomas Jefferson National Accelerator Facility in Newport News, Va. Designed to probe proton structure, specifically the contribution of strange quarks, the experiment has involved an international group of 108 scientists from 19 institutions. First Powder Injection Molding Process For Pure Niobium
Penn State researchers have developed the first powder injection molding process for pure niobium, a biocompatible material similar to platinum and titanium but cheaper. U.S. Adds Wiki to Spy Arsenal
Silver bullet or leaker's dream? Washington's spymasters model a new intelligence-sharing system on Wikipedia.
MP3 Music Downloads
Preview songs, Download Free Music,Burn CDs at ITunes.com
 
|
